Nichole L. Martin
General Counsel chez SERA PROGNOSTICS, INC.
Profil
Nichole L.
Martin is currently the Vice President-Quality & Regulatory at Sera Prognostics, Inc. Prior to this, she worked as the Senior Director-Quality Management at Biora Therapeutics, Inc. from 2018 to 2020 and as the Quality Director-Americas at Q2 Solutions from 2008 to 2015.
Martin holds graduate degrees from The California State University and North Carolina State University.
Postes actifs de Nichole L. Martin
| Sociétés | Poste | Début |
|---|---|---|
| SERA PROGNOSTICS, INC. | General Counsel | 01/05/2020 |
Anciens postes connus de Nichole L. Martin
| Sociétés | Poste | Fin |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2020 |
Q2 Solutions
 Q2 Solutions Medical/Nursing ServicesHealth Services Q2 Solutions provides clinical trials laboratory services. It helps biopharmaceutical, medical device, and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. The company was founded in 2015 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01/01/2015 |
Formation de Nichole L. Martin
| The California State University | Graduate Degree |
| North Carolina State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SERA PROGNOSTICS, INC. | Health Services |
| BIORA THERAPEUTICS, INC. | Health Services |
| Entreprise privées | 1 |
|---|---|
Q2 Solutions
Q2 Solutions Medical/Nursing ServicesHealth Services Q2 Solutions provides clinical trials laboratory services. It helps biopharmaceutical, medical device, and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. The company was founded in 2015 and is headquartered in Morrisville, NC. | Health Services |
